Tag: AstraZeneca

The Drug Controller General of India and the institutional ethics committee at the implementation site are investigating the adverse event as claimed to have been suffered by a trial participant in Chennai.........................

With close to 8 Crore diabetes patients in India, the need for building awareness and research-based effort to provide the much-needed support for early detection and treatment of Diabetes will go a long way in decreasing the uncontrolled incidence of the disease and associated complications......................

While two different dosing regimens demonstrated efficacy with one showing a better profile, no hospitalizations or severe cases of COVID-19 have been reported in participants treated with AZD1222....................

AstraZeneca’s dapagliflozin is the first medicine in SGLT-2i class to move into a new disease area by demonstrating efficacy and safety data for the treatment of patients with CKD...................

India-Sweden Healthcare innovation centre is a collaboration between the Swedish Trade Commissioner’s Office, All India Institute of Medical Sciences, New Delhi (AIIMS Delhi) and All India Institute of Medical Sciences, Jodhpur (AIIMS Jodhpur).......................

As per the terms of the agreement the company has reserved manufacturing capacity to allow for the supply of multiple vaccines to the UK Government in its fight against COVID- 19, including AZD1222, the vaccine co-invented by the University of Oxford...............

The Drugs Controller General of India has given the Serum Institute of India a green light to conduct phase 2 and 3 human trials of the Oxford-AstraZeneca COVID-19 vaccine candidate in India..................

Operation Warp Speed is part of a broader strategy to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics.......................

As per the terms of the agreement, Sun Pharma will be responsible for development, regulatory filings and manufacturing the products covered in the agreement while AstraZeneca will exclusively promote and distribute these products in China...................

The establishment of a new Development Operations Centre by AstraZeneca at Bengaluru supports the development of innovative medicines and hosts clinical trial experts focused on core therapeutic areas................